|
|
Article: BioShield: Government, Biotech Or Is It Government Vs. Biotech?
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Contributing Writer
Washington - The first day of the Biodefense Vaccines, Therapeutics and Diagnostics meeting, hosted by Infocast, ended as it began, with discussion of an uncertain partnership between the government and industry.
While the federal BioShield program has potential with a current proposal of $5.6 billion over eight years, there are areas in which the project falls short - and it has yet to be passed by the Senate. Under BioShield, the Department of Health and Human Services (HHS) would be the procuring authority, although priorities and actions would be set by multi-agency committees at various levels.
According to the ...